These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters. Akkus G, Evran M, Sert M, Tetiker T. Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882 [Abstract] [Full Text] [Related]
7. Circulating E-selectin levels and insulin resistance are associated with early stages of atherosclerosis in nonfunctional adrenal incidentaloma. Delibasi T, Karbek B, Bozkurt NC, Cakir E, Gungunes A, Ünsal ÖÖ, Aslan MS, Cakal E. Arch Endocrinol Metab; 2015 Aug; 59(4):310-7. PubMed ID: 26331318 [Abstract] [Full Text] [Related]
8. Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome. Ribeiro Cavalari EM, de Paula MP, Arruda M, Carraro N, Martins A, de Souza K, Coelho MC, de Oliveira E Silva de Morais NA, Moraes AB, Vieira Neto L. Clin Endocrinol (Oxf); 2018 Nov; 89(5):586-595. PubMed ID: 30044007 [Abstract] [Full Text] [Related]
9. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho FC, Netto BD, Carvalho-Ferreira JP, Oyama LM, Nascimento CM, de Mello MT, Tufik S, Dâmaso AR. Br J Nutr; 2015 Jun 28; 113(12):1920-30. PubMed ID: 25907896 [Abstract] [Full Text] [Related]
10. NEW BIOMARKERS TO PREDICT CARDIOVASCULAR RISK IN PATIENTS WITH ADRENAL INCIDENTALOMA; IRISIN AND NESFATIN-1. Can M, Kocabaş M, Karaköse M, Alsancak Y, Yerlikaya FH, Burgucu HC, Cordan I, Kadiyoran C, Kulaksızoğlu M, Karakurt F. Acta Endocrinol (Buchar); 2022 Jun 28; 18(2):150-155. PubMed ID: 36212257 [Abstract] [Full Text] [Related]
11. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ, Piaditis GP. J Clin Endocrinol Metab; 2014 Aug 28; 99(8):2754-62. PubMed ID: 24712565 [Abstract] [Full Text] [Related]
12. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Pacifico L, Bonci E, Andreoli G, Romaggioli S, Di Miscio R, Lombardo CV, Chiesa C. Nutr Metab Cardiovasc Dis; 2014 Jul 28; 24(7):737-43. PubMed ID: 24656140 [Abstract] [Full Text] [Related]
13. Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism. Karbek B, Cakal E, Cakir E, Bozkurt N, Unsal I, Sahin M, Delibaşi T. Minerva Endocrinol; 2013 Sep 28; 38(3):297-304. PubMed ID: 24126550 [Abstract] [Full Text] [Related]
15. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences? Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, Cuesta Hernández M, Sampedro Núñez MA, Marazuela M. Endocrine; 2019 Dec 28; 66(3):650-659. PubMed ID: 31473918 [Abstract] [Full Text] [Related]
19. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed. de Paula MP, Moraes AB, de Souza MDGC, Cavalari EMR, Campbell RC, Fernandes GDS, Farias MLF, Mendonça LMC, Madeira M, Bouskela E, Kraemer-Aguiar LG, Vieira Neto L. J Endocrinol Invest; 2021 Mar 28; 44(3):609-619. PubMed ID: 32686043 [Abstract] [Full Text] [Related]